"In his morning keynote presentation, Rutledge Ellis-Behnke, a professor at University of Heidelberg in Germany and the Massachusetts Institute of Technology, spoke about his new experimental approaches that employ nanotech to treat vision and other ailments that frequently befall the elderly." . . . .